Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: Results from 2 phase I studies
Surmont, V × Smit, E. F De Jonge, M Aerts, J. G Nackaerts, Kristiaan Vernhout, R Gras, J Van Wijk, A Phernambucq, E. C. J van Meerbeeck, J. P Senan, S Kraaij, C. J Chouaki, N Praag, J van Klaveren, R. J #
Elsevier ireland ltd
Lung cancer vol:69 issue:3 pages:302-306
Background: The objectives were to determine the maximum tolerated dose (MTD) of pemetrexed and cisplatin with concurrent radiotherapy. Secondary objectives include incidence and nature of acute and late toxicities, tumor response and overall survival.